Emerging Therapeutic Modalities

Emerging therapeutic modalities are reshaping the landscape of cancer treatment. Techniques like CAR-T cell therapy, gene editing technologies such as CRISPR, and epigenetic drugs are expanding the arsenal against cancer. These approaches tackle disease at its genetic and molecular roots, offering personalized solutions. Additionally, novel platforms like oncolytic viruses and bispecific antibodies are gaining traction for their ability to target tumors while activating the immune system. The ongoing integration of these therapies into clinical practice signals a new era in oncology, with potential to improve survival rates significantly.